Taylor Hoffman Wealth Management’s Monster Beverage MNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$2.49M Buy
49,909
+1,593
+3% +$84.4K 1.01% 34
2024
Q1
$2.86M Sell
48,316
-748
-2% -$43K 1.22% 33
2023
Q4
$2.83M Buy
49,064
+2,450
+5% +$131K 1.28% 32
2023
Q3
$2.47M Buy
46,614
+87
+0.2% +$4.94K 1.27% 32
2023
Q2
$2.67M Buy
46,527
+2,012
+5% +$114K 1.34% 31
2023
Q1
$2.4M Buy
44,515
+867
+2% +$44.5K 1.32% 31
2022
Q4
$2.22M Sell
43,648
-5,898
-12% -$286K 1.36% 30
2022
Q3
$2.15M Sell
49,546
-440
-0.9% -$20.3K 1.13% 37
2022
Q2
$2.36M Buy
49,986
+8
+0% +$348 1.16% 37
2022
Q1
$2M Buy
49,978
+842
+2% +$35.3K 0.8% 46
2021
Q4
$2.36M Buy
49,136
+16,372
+50% +$728K 0.9% 41
2021
Q3
$1.47M Buy
+32,764
New +$1.55M 0.63% 55

Other funds holding MNST

Taylor Hoffman Wealth Management's MNST Position: Q2 2024 in Review

Taylor Hoffman Wealth Management increased its Monster Beverage (MNST) stake by 3.3% in Q2 2024, buying an estimated $84.4K and bringing the position to 49,909 shares worth $2.49M. The position accounts for 1.01% of the portfolio, ranked #34.

Taylor Hoffman Wealth Management first reported a position in MNST in Q3 2021 and has held it in 12 quarters since. The position peaked at $2.86M in Q1 2024. 929 funds tracked by Wall St. Rank hold MNST as of Q2 2024.

  • Taylor Hoffman Wealth Management held 49,909 shares of Monster Beverage worth $2.49M as of Q2 2024.
  • Taylor Hoffman Wealth Management bought 1,593 Monster Beverage shares in Q2 2024, an estimated $84.4K.
  • Monster Beverage made up 1.01% of Taylor Hoffman Wealth Management's portfolio in Q2 2024, its #34 holding.
  • Taylor Hoffman Wealth Management first reported a position in Monster Beverage in Q3 2021 and has held it in 12 quarters since.
  • Taylor Hoffman Wealth Management's Monster Beverage position peaked at $2.86M in Q1 2024.
  • 929 funds tracked by Wall St. Rank held Monster Beverage as of Q2 2024.

Based on Taylor Hoffman Wealth Management's 13F filing for Q2 2024, filed 9 Aug 2024.